THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Grant Skrepnek to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications Grant Skrepnek has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Grant Skrepnek
Connection Strength
0.241
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach. Pharmacotherapy. 2005 Mar; 25(3):325-34.
    View in: PubMed
    Score: 0.241
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES